Tags

Type your tag names separated by a space and hit enter

[Cardiovascular disease in those aged 55 years and over controlled with a combined pill against 4 risk factors: some brief comments].
Ned Tijdschr Geneeskd. 2003 Aug 09; 147(32):1537-8.NT

Abstract

It was recently proposed that people with a high absolute cardiovascular risk, for example those aged 55 years and over, might considerably benefit from a combined pill that includes proven treatments such as a statins, antihypertensives, antiplatelet therapy and folic acid. Although conceptually attractive, certain negative effects need to be considered. A strategy to treat the population aged 55 years and over might yield large benefits in high-risk patients with fairly normal values for risk factors that are currently often left untreated. It may, however, also lead to the undertreatment of patients with abnormally high values of individual risk factors and to the overtreatment of low-risk patients. In these low-risk patients, the side effects of aspirin and blood-pressure lowering treatment might outweigh the benefits. Due to the high costs and also the availability of generic drugs, it is difficult to envision trials that will address these issues. Therefore, the acceptance and implementation of this intriguing concept by health authorities and insurance companies remains doubtful.

Authors+Show Affiliations

Rabelink TJ
Universitair Medisch Centrum Utrecht, divisie Interne Geneeskunde en Dermatologie, Postbus 85.500, 3508 GA Utrecht. t.rabelink@azu.nl

MeSH

Antihypertensive AgentsCardiovascular DiseasesDrug Therapy, CombinationFemaleFolic AcidHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedPlatelet Aggregation InhibitorsRisk Factors

Pub Type(s)

English Abstract
Journal Article

Language

dut

PubMed ID

12942841

Citation

Rabelink, T J.. "[Cardiovascular Disease in Those Aged 55 Years and Over Controlled With a Combined Pill Against 4 Risk Factors: some Brief Comments]." Nederlands Tijdschrift Voor Geneeskunde, vol. 147, no. 32, 2003, pp. 1537-8.
Rabelink TJ. [Cardiovascular disease in those aged 55 years and over controlled with a combined pill against 4 risk factors: some brief comments]. Ned Tijdschr Geneeskd. 2003;147(32):1537-8.
Rabelink, T. J. (2003). [Cardiovascular disease in those aged 55 years and over controlled with a combined pill against 4 risk factors: some brief comments]. Nederlands Tijdschrift Voor Geneeskunde, 147(32), 1537-8.
Rabelink TJ. [Cardiovascular Disease in Those Aged 55 Years and Over Controlled With a Combined Pill Against 4 Risk Factors: some Brief Comments]. Ned Tijdschr Geneeskd. 2003 Aug 9;147(32):1537-8. PubMed PMID: 12942841.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Cardiovascular disease in those aged 55 years and over controlled with a combined pill against 4 risk factors: some brief comments]. A1 - Rabelink,T J, PY - 2003/8/29/pubmed PY - 2003/10/8/medline PY - 2003/8/29/entrez SP - 1537 EP - 8 JF - Nederlands tijdschrift voor geneeskunde JO - Ned Tijdschr Geneeskd VL - 147 IS - 32 N2 - It was recently proposed that people with a high absolute cardiovascular risk, for example those aged 55 years and over, might considerably benefit from a combined pill that includes proven treatments such as a statins, antihypertensives, antiplatelet therapy and folic acid. Although conceptually attractive, certain negative effects need to be considered. A strategy to treat the population aged 55 years and over might yield large benefits in high-risk patients with fairly normal values for risk factors that are currently often left untreated. It may, however, also lead to the undertreatment of patients with abnormally high values of individual risk factors and to the overtreatment of low-risk patients. In these low-risk patients, the side effects of aspirin and blood-pressure lowering treatment might outweigh the benefits. Due to the high costs and also the availability of generic drugs, it is difficult to envision trials that will address these issues. Therefore, the acceptance and implementation of this intriguing concept by health authorities and insurance companies remains doubtful. SN - 0028-2162 UR - https://www.unboundmedicine.com/medline/citation/12942841/[Cardiovascular_disease_in_those_aged_55_years_and_over_controlled_with_a_combined_pill_against_4_risk_factors:_some_brief_comments]_ DB - PRIME DP - Unbound Medicine ER -